Avacta becomes distributor for Cold Spring’s Optim

Pharmaceutical and diagnostics technology provider Avacta has signed a distribution agreement for Optim, a low-volume protein analysis system, with biotechnology firm Cold Spring in Mainland China, Hong Kong and Taiwan.

Optim has been developed to accelerate and reduce the cost of drug development by providing early analysis of compounds to identify the best candidates and to define the optimal processing conditions.